Microvascular decompression for hemifacial spasm

analyses of operative complications in 1582 consecutive patients

Ryoong Huh, In Bo Han, Ji Young Moon, JinWoo Chang, Sang Sup Chung

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: Microvascular decompression is the most reliable treatment for HFS, but it may cause complications. The aim was to identify factors affecting the prognosis after MVD and to establish appropriate means to reduce complications. Method: We retrospectively reviewed 1524 patients with HFS who underwent MVD and were followed for more than 6 months since January 1987. The mean follow-up duration was 30.9 months (6-197 months). Results: The effect of MVD was satisfying (excellent or good) in 94.6% (n = 1442). The failure and recurrence rates were 2.1% (n = 32) and 0.4% (n = 6), respectively. Postoperative complications were noted in 545 (35.8%) patients. Among them, facial palsy, hearing deficit, and low cranial nerve palsies were found in 18.6% (n = 283), 7.2% (n = 109), and 2.8% (n = 43), respectively. However, permanent facial weakness, hearing deficit, and lower cranial nerve palsies such as hoarseness and dysphagia were encountered in 1.2% (n = 18), 2.1% (n = 32), and 0.1% (n = 2), respectively. The more immediate and severe the facial palsy was, the more permanent it remained, with statistical significance (P < .05). There was a trend that the more immediate and severe the hearing deficit was, the more permanent the deficit remained, without statistical significance (P = .673). Conclusion: Early (occurrence within 24 hours after operation) and severe cranial nerve deficits, including facial, hearing, and lower cranial nerve deficits after MVD, entail the risk to stay permanent.

Original languageEnglish
Pages (from-to)153-157
Number of pages5
JournalSurgical Neurology
Volume69
Issue number2
DOIs
Publication statusPublished - 2008 Feb 1

Fingerprint

Microvascular Decompression Surgery
Hemifacial Spasm
Hearing
Cranial Nerve Diseases
Cranial Nerves
Facial Paralysis
Hoarseness
Deglutition Disorders
Recurrence

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Surgery

Cite this

Huh, Ryoong ; Han, In Bo ; Moon, Ji Young ; Chang, JinWoo ; Chung, Sang Sup. / Microvascular decompression for hemifacial spasm : analyses of operative complications in 1582 consecutive patients. In: Surgical Neurology. 2008 ; Vol. 69, No. 2. pp. 153-157.
@article{418e85ba08224217a79f7d6f5b5a380e,
title = "Microvascular decompression for hemifacial spasm: analyses of operative complications in 1582 consecutive patients",
abstract = "Background: Microvascular decompression is the most reliable treatment for HFS, but it may cause complications. The aim was to identify factors affecting the prognosis after MVD and to establish appropriate means to reduce complications. Method: We retrospectively reviewed 1524 patients with HFS who underwent MVD and were followed for more than 6 months since January 1987. The mean follow-up duration was 30.9 months (6-197 months). Results: The effect of MVD was satisfying (excellent or good) in 94.6{\%} (n = 1442). The failure and recurrence rates were 2.1{\%} (n = 32) and 0.4{\%} (n = 6), respectively. Postoperative complications were noted in 545 (35.8{\%}) patients. Among them, facial palsy, hearing deficit, and low cranial nerve palsies were found in 18.6{\%} (n = 283), 7.2{\%} (n = 109), and 2.8{\%} (n = 43), respectively. However, permanent facial weakness, hearing deficit, and lower cranial nerve palsies such as hoarseness and dysphagia were encountered in 1.2{\%} (n = 18), 2.1{\%} (n = 32), and 0.1{\%} (n = 2), respectively. The more immediate and severe the facial palsy was, the more permanent it remained, with statistical significance (P < .05). There was a trend that the more immediate and severe the hearing deficit was, the more permanent the deficit remained, without statistical significance (P = .673). Conclusion: Early (occurrence within 24 hours after operation) and severe cranial nerve deficits, including facial, hearing, and lower cranial nerve deficits after MVD, entail the risk to stay permanent.",
author = "Ryoong Huh and Han, {In Bo} and Moon, {Ji Young} and JinWoo Chang and Chung, {Sang Sup}",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.surneu.2007.07.027",
language = "English",
volume = "69",
pages = "153--157",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "2",

}

Microvascular decompression for hemifacial spasm : analyses of operative complications in 1582 consecutive patients. / Huh, Ryoong; Han, In Bo; Moon, Ji Young; Chang, JinWoo; Chung, Sang Sup.

In: Surgical Neurology, Vol. 69, No. 2, 01.02.2008, p. 153-157.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microvascular decompression for hemifacial spasm

T2 - analyses of operative complications in 1582 consecutive patients

AU - Huh, Ryoong

AU - Han, In Bo

AU - Moon, Ji Young

AU - Chang, JinWoo

AU - Chung, Sang Sup

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Background: Microvascular decompression is the most reliable treatment for HFS, but it may cause complications. The aim was to identify factors affecting the prognosis after MVD and to establish appropriate means to reduce complications. Method: We retrospectively reviewed 1524 patients with HFS who underwent MVD and were followed for more than 6 months since January 1987. The mean follow-up duration was 30.9 months (6-197 months). Results: The effect of MVD was satisfying (excellent or good) in 94.6% (n = 1442). The failure and recurrence rates were 2.1% (n = 32) and 0.4% (n = 6), respectively. Postoperative complications were noted in 545 (35.8%) patients. Among them, facial palsy, hearing deficit, and low cranial nerve palsies were found in 18.6% (n = 283), 7.2% (n = 109), and 2.8% (n = 43), respectively. However, permanent facial weakness, hearing deficit, and lower cranial nerve palsies such as hoarseness and dysphagia were encountered in 1.2% (n = 18), 2.1% (n = 32), and 0.1% (n = 2), respectively. The more immediate and severe the facial palsy was, the more permanent it remained, with statistical significance (P < .05). There was a trend that the more immediate and severe the hearing deficit was, the more permanent the deficit remained, without statistical significance (P = .673). Conclusion: Early (occurrence within 24 hours after operation) and severe cranial nerve deficits, including facial, hearing, and lower cranial nerve deficits after MVD, entail the risk to stay permanent.

AB - Background: Microvascular decompression is the most reliable treatment for HFS, but it may cause complications. The aim was to identify factors affecting the prognosis after MVD and to establish appropriate means to reduce complications. Method: We retrospectively reviewed 1524 patients with HFS who underwent MVD and were followed for more than 6 months since January 1987. The mean follow-up duration was 30.9 months (6-197 months). Results: The effect of MVD was satisfying (excellent or good) in 94.6% (n = 1442). The failure and recurrence rates were 2.1% (n = 32) and 0.4% (n = 6), respectively. Postoperative complications were noted in 545 (35.8%) patients. Among them, facial palsy, hearing deficit, and low cranial nerve palsies were found in 18.6% (n = 283), 7.2% (n = 109), and 2.8% (n = 43), respectively. However, permanent facial weakness, hearing deficit, and lower cranial nerve palsies such as hoarseness and dysphagia were encountered in 1.2% (n = 18), 2.1% (n = 32), and 0.1% (n = 2), respectively. The more immediate and severe the facial palsy was, the more permanent it remained, with statistical significance (P < .05). There was a trend that the more immediate and severe the hearing deficit was, the more permanent the deficit remained, without statistical significance (P = .673). Conclusion: Early (occurrence within 24 hours after operation) and severe cranial nerve deficits, including facial, hearing, and lower cranial nerve deficits after MVD, entail the risk to stay permanent.

UR - http://www.scopus.com/inward/record.url?scp=38749132549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749132549&partnerID=8YFLogxK

U2 - 10.1016/j.surneu.2007.07.027

DO - 10.1016/j.surneu.2007.07.027

M3 - Article

VL - 69

SP - 153

EP - 157

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 2

ER -